<VariationArchive VariationID="159788" VariationName="NM_007254.4(PNKP):c.1295_1298+6del" VariationType="Deletion" Accession="VCV000159788" Version="24" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-05-01" DateCreated="2014-11-23" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="169587" VariationID="159788">
      <GeneList>
        <Gene Symbol="PNKP" FullName="polynucleotide kinase 3'-phosphatase" GeneID="11284" HGNC_ID="HGNC:9154" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="49861204" stop="49867576" display_start="49861204" display_stop="49867576" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="50364459" stop="50370821" display_start="50364459" display_stop="50370821" Strand="-" />
          </Location>
          <OMIM>605610</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_007254.4(PNKP):c.1295_1298+6del</Name>
      <CanonicalSPDI>NC_000019.10:49861765:CGCTACCTGGCGC:CGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="49861766" stop="49861775" display_start="49861766" display_stop="49861775" variantLength="10" positionVCF="49861765" referenceAlleleVCF="ACGCTACCTGG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="50365023" stop="50365032" display_start="50365023" display_stop="50365032" variantLength="10" positionVCF="50365022" referenceAlleleVCF="ACGCTACCTGG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007254.2" sequenceAccession="NM_007254" sequenceVersion="2" change="c.1295_1298+6delCCAGGTAGCG">
            <Expression>NM_007254.2:c.1295_1298+6delCCAGGTAGCG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.49861769_49861778del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.49861769_49861778del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.50365026_50365035del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.50365026_50365035del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027717.1" sequenceAccession="NG_027717" sequenceVersion="1" change="g.10791_10800del">
            <Expression>NG_027717.1:g.10791_10800del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_050666.1" sequenceAccession="NG_050666" sequenceVersion="1" change="g.17926_17935del">
            <Expression>NG_050666.1:g.17926_17935del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007254.4" sequenceAccession="NM_007254" sequenceVersion="4" change="c.1295_1298+6del" MANESelect="true">
            <Expression>NM_007254.4:c.1295_1298+6del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA251143" DB="ClinGen" />
        <XRef Type="rs" ID="587784366" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_007254.4(PNKP):c.1295_1298+6del AND Microcephaly, seizures, and developmental delay" Accession="RCV000147346" Version="6">
        <ClassifiedConditionList TraitSetID="1332">
          <ClassifiedCondition DB="MedGen" ID="C3150667">Microcephaly, seizures, and developmental delay</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-06-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1295_1298+6del AND not provided" Accession="RCV000188473" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-04-06" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1295_1298+6del AND Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia" Accession="RCV000825541" Version="6">
        <ClassifiedConditionList TraitSetID="1218">
          <ClassifiedCondition DB="MedGen" ID="C1859598">Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_007254.4(PNKP):c.1295_1298+6del AND Developmental and epileptic encephalopathy, 12" Accession="RCV001070856" Version="8">
        <ClassifiedConditionList TraitSetID="6739">
          <ClassifiedCondition DB="MedGen" ID="C3150988">Developmental and epileptic encephalopathy, 12</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-19" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2014-11-23" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20118933</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25728773</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31041400</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31167812</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32504494</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35426160</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PNKP</URL>
        </Citation>
        <DescriptionHistory Dated="2018-03-30">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6739" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15767" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 12</ElementValue>
                <XRef ID="MONDO:0013389" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 12</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+12/8340" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE12</ElementValue>
                <XRef Type="MIM" ID="613722" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13318" />
                <XRef ID="13318" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3150988" DB="MedGen" />
              <XRef ID="MONDO:0013389" DB="MONDO" />
              <XRef Type="MIM" ID="613722" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1332" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6933" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Microcephaly, seizures, and developmental delay</ElementValue>
                <XRef ID="MONDO:0013254" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 10</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+10/8338" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MCSZ</ElementValue>
                <XRef Type="MIM" ID="613402" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE10</ElementValue>
                <XRef Type="MIM" ID="613402" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10933" />
                <XRef ID="10933" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C3150667" DB="MedGen" />
              <XRef ID="MONDO:0013254" DB="MONDO" />
              <XRef Type="MIM" ID="613402" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1218" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="347" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ataxia-oculomotor apraxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-telangiectasia-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early-onset cerebellar ataxia with hypoalbuminemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adult onset ataxia with oculomotor apraxia</ElementValue>
                <XRef ID="Adult+onset+ataxia+with+oculomotor+apraxia/7641" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia</ElementValue>
                <XRef ID="MONDO:0008842" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-oculomotor apraxia type 1</ElementValue>
                <XRef ID="1168" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EAOH</ElementValue>
                <XRef Type="MIM" ID="208920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AOA</ElementValue>
                <XRef Type="MIM" ID="208920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">AOA1</ElementValue>
                <XRef Type="MIM" ID="208920" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EOCA-HA</ElementValue>
                <XRef Type="MIM" ID="208920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9283" />
                <XRef ID="9283" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Ataxia with oculomotor apraxia type 1 (AOA1) is characterized by childhood onset of slowly progressive cerebellar ataxia, followed by oculomotor apraxia and a severe primary motor peripheral axonal motor neuropathy. The first manifestation is progressive gait imbalance (mean age of onset: 4.3 years; range: 2-10 years), followed by dysarthria, then upper-limb dysmetria with mild intention tremor. Oculomotor apraxia, usually noticed a few years after the onset of ataxia, progresses to external ophthalmoplegia. All affected individuals have generalized areflexia followed by a peripheral neuropathy and quadriplegia with loss of ambulation about seven to ten years after onset. Hands and feet are short and atrophic. Chorea and upper-limb dystonia are common. Intellect remains normal in some individuals; in others, different degrees of cognitive impairment have been observed.</Attribute>
                <XRef ID="NBK1456" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301629</ID>
                <ID Source="BookShelf">NBK1456</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/ENS, 2014">
                <ID Source="PubMed">24418350</ID>
              </Citation>
              <XRef ID="1168" DB="Orphanet" />
              <XRef ID="C1859598" DB="MedGen" />
              <XRef ID="MONDO:0008842" DB="MONDO" />
              <XRef Type="MIM" ID="208920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="342557" SubmissionDate="2014-09-11" DateLastUpdated="2014-11-23" DateCreated="2014-11-23">
        <ClinVarSubmissionID localKey="NM_007254.3(PNKP):c.1295_1298+6del" />
        <ClinVarAccession Accession="SCV000194721" DateUpdated="2014-11-23" DateCreated="2014-11-23" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-06-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Abbrev="ACMG, 2015" Type="practice guideline">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" start="50365023" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007254.3:c.1295_1298+6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Epileptic encephalopathy, early infantile, 10</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="446824" SubmissionDate="2015-07-30" DateLastUpdated="2015-08-07" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="49146" />
        <ClinVarAccession Accession="SCV000242087" DateUpdated="2015-08-07" DateCreated="2015-08-07" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-09-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1295_1298+6delCCAGGTAGCG mutation in the PNKP gene results in the deletion of ten nucleotides at the exon 14/intron 14 boundary, thereby destroying the canonical splice donor site in intron 14. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense-mediated mRNA decay or to an abnormal protein product if the message is used for protein translation. Although this mutation has not been previously reported to our knowledge, it is considered a disease-causing mutation.The variant is found in CHILD-EPI,EPILEPSY panel(s).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007254.2:c.1295_1298+6delCCAGGTAGCG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1373191" SubmissionDate="2018-09-19" DateLastUpdated="2018-05-03" DateCreated="2015-08-07">
        <ClinVarSubmissionID localKey="27571_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000700789" DateUpdated="2018-05-03" DateCreated="2015-08-07" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-06-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="19" alternateAllele="-" referenceAllele="CGCTACCTGG" start="50365023" stop="50365032" variantLength="10" />
            <GeneLocation>NM_007254.3:Ex14</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="dbSNP" ID="587784366" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PNKP</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3961731" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="74f18af2e1c7f5ed26feb1b2cc352d71d3bd7068ee72e22be1b4238bb49c901e|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002019446" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_007254.4:c.1295_1298+6del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2401795" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="266249|MedGen:C3150988" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001236133" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20118933</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25728773</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31167812</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32504494</ID>
          </Citation>
          <Comment>This variant results in the deletion of part of exon 14 (c.1295_1298+6del) of the PNKP gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PNKP are known to be pathogenic (PMID: 20118933, 25728773). This variant is present in population databases (rs587784366, gnomAD 0.03%). This variant has been observed in individual(s) with PNKP-related conditions (PMID: 31167812). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 159788). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects PNKP function (PMID: 32504494). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.50365023_50365032del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3150988" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1894651" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="71722058|Orphanet:ORPHA1168" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000966857" DateUpdated="2024-04-20" DateCreated="2019-08-26" Type="SCV" Version="2" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31041400</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35426160</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32504494</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31167812</ID>
          </Citation>
          <Comment>The c.1295_1298+6del (NM_007254.3 c.1295_1298+6delCCAGGTAGCG) variant in PNKP has been reported in the compound heterozygous state in 1 individual with microcephaly with early onset seizures (MCSZ), in 1 individual with motor neuropathy, and in 2 individuals with ataxia with oculomotor apraxia and segregated with disease in 2 affected relatives from 1 family (Previtali 2019 PMID: 31167812, Kalasova 2019 PMID: 31041400, da Costa 2022 PMID: 35426160). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 159788) and has been identified in 0.06% (3/4832) of South Asian and 0.0029% (2/68006) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2). This variant is a deletion of ten nucleotides at the exon 14/intron 14 boundary, thereby destroying the canonical splice donor site in intron 14. It is predicted to cause altered splicing, leading to an abnormal or absent protein. Biallelic loss of function of the PNKP gene has been associated with ataxia with oculomotor apraxia. Functional studies in patient fibroblasts provide some evidence that this variant reduced protein expression and activity and were more susceptible to single strand breaks due to reduced repair activity (Kalasova 2019 PMID: 31041400, Kalasova 2020 PMID: 32504494). In summary, the c.1295_1298+6delCCAGGTAGCG variant in PNKP meets criteria to be classified as pathogenic for PNKP-related disorders, such as autosomal recessive ataxia with oculomotor apraxia, and autosomal recessive microcephaly, seizures and developmental delay. ACMG/AMP Criteria applied: PVS1, PM3_Strong, PP1, PS3_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PNKP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_007254.4:exon 14</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.10:g.49861766_49861775delCGCTACCTGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA1168" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="342557" TraitType="Disease" MappingType="Name" MappingValue="Epileptic encephalopathy, early infantile, 10" MappingRef="Preferred">
        <MedGen CUI="C3150667" Name="Microcephaly, seizures, and developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2401795" TraitType="Disease" MappingType="XRef" MappingValue="C3150988" MappingRef="MedGen">
        <MedGen CUI="C3150988" Name="Developmental and epileptic encephalopathy, 12" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3961731" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1373191" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="446824" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1894651" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA1168" MappingRef="Orphanet">
        <MedGen CUI="C1859598" Name="Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

